We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you choose.
Everolimus (Votubia®) for treatment of angiomyolipomas associated with tuberous sclerosis
NHS England will commission everolimus (Votubia®) for treatment of TSC-associated AMLs in children (≥ 3years old) and adults, in accordance with the criteria outlined in this document.
